Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice

Shan Zeng, Nikki Feirt, Michael Goldstein, James Guarrera, Nikalesh Ippagunta, Udeme Ekong, Hao Dun, Yan Lu, Wu Qu, Ann Marie Schmidt, Jean C. Emond

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Hepatic ischemia/reperfusion (I/R) injury associated with liver transplantation and hepatic resection is characterized by hepatocellular damage and a deleterious inflammatory response. In this study, we examined whether receptor for advanced glycation end product (RAGE) activation is linked to mechanisms accentuating inflammation on I/R in a murine model of total hepatic ischemia. Animals treated with soluble RAGE (sRAGE), the extracellular ligand-binding domain of RAGE, displayed increased survival after total hepatic I/R compared with vehicle treatment. TUNEL assay and histologic analysis revealed that blockade of RAGE was highly protective against hepatocellular death and necrosis on I/R; in parallel, proliferating cell nuclear antigen was enhanced in livers of mice treated with sRAGE. Rapid activation of p38, p44/42, stress-activated protein kinase and c-Jun N-terminal kinase mitogen-activated protein kinases, signal transducer and activator of transcription-3, and nuclear translocation of activator protein-1 was evident at early times on I/R. In the remnants of sRAGE-treated livers, however, activation of each of these signaling and transcription factor pathways was strikingly decreased. sRAGE-treated remnants displayed enhanced activation of nuclear factor κB, in parallel with increased transcripts for the proregenerative cytokine, tumor necrosis factor-α. In conclusion, these data suggest that RAGE modulates hepatic I/R injury, at least in part by activation of key signaling pathways linked to proinflammatory and cell death-promoting responses. We propose that blockade of this pathway may represent a novel strategy to attenuate injury in hepatic I/R and to facilitate regeneration.

Original languageEnglish (US)
Pages (from-to)422-432
Number of pages11
JournalHepatology
Volume39
Issue number2
DOIs
StatePublished - Feb 2004
Externally publishedYes

Fingerprint

Reperfusion Injury
Liver
Ischemia
Reperfusion
STAT3 Transcription Factor
Advanced Glycosylation End Product-Specific Receptor
JNK Mitogen-Activated Protein Kinases
Transcription Factor AP-1
In Situ Nick-End Labeling
Proliferating Cell Nuclear Antigen
Heat-Shock Proteins
Mitogen-Activated Protein Kinases
Liver Transplantation
Protein Kinases
Regeneration
Cell Death
Transcription Factors
Necrosis
Tumor Necrosis Factor-alpha
Cytokines

ASJC Scopus subject areas

  • Hepatology

Cite this

Zeng, S., Feirt, N., Goldstein, M., Guarrera, J., Ippagunta, N., Ekong, U., ... Emond, J. C. (2004). Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice. Hepatology, 39(2), 422-432. https://doi.org/10.1002/hep.20045

Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice. / Zeng, Shan; Feirt, Nikki; Goldstein, Michael; Guarrera, James; Ippagunta, Nikalesh; Ekong, Udeme; Dun, Hao; Lu, Yan; Qu, Wu; Schmidt, Ann Marie; Emond, Jean C.

In: Hepatology, Vol. 39, No. 2, 02.2004, p. 422-432.

Research output: Contribution to journalArticle

Zeng, S, Feirt, N, Goldstein, M, Guarrera, J, Ippagunta, N, Ekong, U, Dun, H, Lu, Y, Qu, W, Schmidt, AM & Emond, JC 2004, 'Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice', Hepatology, vol. 39, no. 2, pp. 422-432. https://doi.org/10.1002/hep.20045
Zeng, Shan ; Feirt, Nikki ; Goldstein, Michael ; Guarrera, James ; Ippagunta, Nikalesh ; Ekong, Udeme ; Dun, Hao ; Lu, Yan ; Qu, Wu ; Schmidt, Ann Marie ; Emond, Jean C. / Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice. In: Hepatology. 2004 ; Vol. 39, No. 2. pp. 422-432.
@article{164763efcd02458dad4cb5093f280d57,
title = "Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice",
abstract = "Hepatic ischemia/reperfusion (I/R) injury associated with liver transplantation and hepatic resection is characterized by hepatocellular damage and a deleterious inflammatory response. In this study, we examined whether receptor for advanced glycation end product (RAGE) activation is linked to mechanisms accentuating inflammation on I/R in a murine model of total hepatic ischemia. Animals treated with soluble RAGE (sRAGE), the extracellular ligand-binding domain of RAGE, displayed increased survival after total hepatic I/R compared with vehicle treatment. TUNEL assay and histologic analysis revealed that blockade of RAGE was highly protective against hepatocellular death and necrosis on I/R; in parallel, proliferating cell nuclear antigen was enhanced in livers of mice treated with sRAGE. Rapid activation of p38, p44/42, stress-activated protein kinase and c-Jun N-terminal kinase mitogen-activated protein kinases, signal transducer and activator of transcription-3, and nuclear translocation of activator protein-1 was evident at early times on I/R. In the remnants of sRAGE-treated livers, however, activation of each of these signaling and transcription factor pathways was strikingly decreased. sRAGE-treated remnants displayed enhanced activation of nuclear factor κB, in parallel with increased transcripts for the proregenerative cytokine, tumor necrosis factor-α. In conclusion, these data suggest that RAGE modulates hepatic I/R injury, at least in part by activation of key signaling pathways linked to proinflammatory and cell death-promoting responses. We propose that blockade of this pathway may represent a novel strategy to attenuate injury in hepatic I/R and to facilitate regeneration.",
author = "Shan Zeng and Nikki Feirt and Michael Goldstein and James Guarrera and Nikalesh Ippagunta and Udeme Ekong and Hao Dun and Yan Lu and Wu Qu and Schmidt, {Ann Marie} and Emond, {Jean C.}",
year = "2004",
month = "2",
doi = "10.1002/hep.20045",
language = "English (US)",
volume = "39",
pages = "422--432",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice

AU - Zeng, Shan

AU - Feirt, Nikki

AU - Goldstein, Michael

AU - Guarrera, James

AU - Ippagunta, Nikalesh

AU - Ekong, Udeme

AU - Dun, Hao

AU - Lu, Yan

AU - Qu, Wu

AU - Schmidt, Ann Marie

AU - Emond, Jean C.

PY - 2004/2

Y1 - 2004/2

N2 - Hepatic ischemia/reperfusion (I/R) injury associated with liver transplantation and hepatic resection is characterized by hepatocellular damage and a deleterious inflammatory response. In this study, we examined whether receptor for advanced glycation end product (RAGE) activation is linked to mechanisms accentuating inflammation on I/R in a murine model of total hepatic ischemia. Animals treated with soluble RAGE (sRAGE), the extracellular ligand-binding domain of RAGE, displayed increased survival after total hepatic I/R compared with vehicle treatment. TUNEL assay and histologic analysis revealed that blockade of RAGE was highly protective against hepatocellular death and necrosis on I/R; in parallel, proliferating cell nuclear antigen was enhanced in livers of mice treated with sRAGE. Rapid activation of p38, p44/42, stress-activated protein kinase and c-Jun N-terminal kinase mitogen-activated protein kinases, signal transducer and activator of transcription-3, and nuclear translocation of activator protein-1 was evident at early times on I/R. In the remnants of sRAGE-treated livers, however, activation of each of these signaling and transcription factor pathways was strikingly decreased. sRAGE-treated remnants displayed enhanced activation of nuclear factor κB, in parallel with increased transcripts for the proregenerative cytokine, tumor necrosis factor-α. In conclusion, these data suggest that RAGE modulates hepatic I/R injury, at least in part by activation of key signaling pathways linked to proinflammatory and cell death-promoting responses. We propose that blockade of this pathway may represent a novel strategy to attenuate injury in hepatic I/R and to facilitate regeneration.

AB - Hepatic ischemia/reperfusion (I/R) injury associated with liver transplantation and hepatic resection is characterized by hepatocellular damage and a deleterious inflammatory response. In this study, we examined whether receptor for advanced glycation end product (RAGE) activation is linked to mechanisms accentuating inflammation on I/R in a murine model of total hepatic ischemia. Animals treated with soluble RAGE (sRAGE), the extracellular ligand-binding domain of RAGE, displayed increased survival after total hepatic I/R compared with vehicle treatment. TUNEL assay and histologic analysis revealed that blockade of RAGE was highly protective against hepatocellular death and necrosis on I/R; in parallel, proliferating cell nuclear antigen was enhanced in livers of mice treated with sRAGE. Rapid activation of p38, p44/42, stress-activated protein kinase and c-Jun N-terminal kinase mitogen-activated protein kinases, signal transducer and activator of transcription-3, and nuclear translocation of activator protein-1 was evident at early times on I/R. In the remnants of sRAGE-treated livers, however, activation of each of these signaling and transcription factor pathways was strikingly decreased. sRAGE-treated remnants displayed enhanced activation of nuclear factor κB, in parallel with increased transcripts for the proregenerative cytokine, tumor necrosis factor-α. In conclusion, these data suggest that RAGE modulates hepatic I/R injury, at least in part by activation of key signaling pathways linked to proinflammatory and cell death-promoting responses. We propose that blockade of this pathway may represent a novel strategy to attenuate injury in hepatic I/R and to facilitate regeneration.

UR - http://www.scopus.com/inward/record.url?scp=10744229479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744229479&partnerID=8YFLogxK

U2 - 10.1002/hep.20045

DO - 10.1002/hep.20045

M3 - Article

C2 - 14767995

AN - SCOPUS:10744229479

VL - 39

SP - 422

EP - 432

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -